CoChat

Erythropoietin protects from axotomy-induced degeneration of retinal ganglion cells by activating ERK-1/-2

Open access
Kilic, Ülkan, Kilic, Ertugrul, Soliz, Jorge, Bassetti, Claudio L., Gassmann, Max, Hermann, Dirk M. · 2005 · The FASEB Journal

The DOI matches its Crossref record; the references it cites are not checked yet.

Abstract

Apart from its hematopoietic function, erythropoietin (Epo) exerts neuroprotective activity upon reduced oxygenation or ischemia of brain, retina, and spinal cord. To examine whether Epo has an impact on the retrograde degeneration of retinal ganglion cells (RGCs) following optic nerve transection in vivo, we made use of our transgenic mouse line tg21 that constitutively expresses human Epo preferentially in neuronal cells without inducing polycythemia. We show that the tg21 retina expresses human Epo and that RGCs in this mouse line carry the Epo receptor. Upon axotomy, the RGCs of Epo transgenic tg21 mice were protected against degeneration, as compared with wild‐type control animals. Western blot analysis revealed decreased phosphorylation levels of STAT‐5 and reduced expression of Bcl‐X L in RGCs of axotomized tg21 animals, suggesting that the corresponding pathways are not crucial for Epo's neuroprotective activity. Increased phosphorylation levels of ERK‐1/‐2 and Akt, as well as decreased caspase‐3 activity, however, were observed in injured tg21 retinae. Injection of selective inhibitors of ERK‐1/‐2 (PD98059) or Akt (Wortmannin) pathways into the vitreous space revealed that transgenic Epo protected the RGCs by a pathway involving ERK‐1/‐2 but not Akt. In view that axotomy‐induced degeneration of RGC occurs slowly, and considering the earlier data on the safety and efficacy of Epo in human stroke patients, we predict the clinical implementation of recombinant human Epo not only in patients with acute ischemic stroke, but also with more delayed degenerative neurological diseases.

Overview

Integrity signals

Registry

Crossref · 10.1096/fj.04-2493fje

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

The citation lists are queued

They are fetched later and appear here then.

References 29 · Cited by 134

Research works printed but not linked: 1

  1. 10.1097/01.WCB.0000050061.57184.AE · doi:10.1097/01.wcb.0000050061.57184.ae · Paper page

Metadata

Authors
Kilic, Ü., Kilic, E., Soliz, J., Bassetti, C. L., Gassmann, M., & Hermann, D. M.
Affiliations
  • Department of Neurology University Hospital Zurich (USZ)
  • University of Zurich (CH)
  • University Hospital Zurich (CH)
Venue
The FASEB Journal
Publisher
Wiley
Published
2004-11-19
Volume
19
Issue
2
Pages
1-14
ISSN
  • 0892-6638 (ISSN-L)
  • 1530-6860
OpenAlex
W2133134763
Cited by
134
References
29
Citations by year
2026: 2 · 2024: 1 · 2023: 2 · 2022: 3 · 2021: 2 · 2020: 4 · 2019: 3 · 2018: 5 · 2017: 3 · 2016: 5 · 2015: 8 · 2014: 5 · 2013: 3 · 2012: 5
FWCI
6.50
Type
journal article
Language
en
Open access
Locations
  • The FASEB Journal (publishedVersion)
  • PubMed (publishedVersion)
  • Zurich Open Repository and Archive (University of Zurich) (acceptedVersion)
  • Zurich Open Repository and Archive (University of Zurich) (submittedVersion)
  • Zurich Open Repository and Archive (University of Zurich)
Funders
  • Northern Cancer Care and Research Society
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (3200B0-100790/1, 3100A0-1002/4)
Topics
  • Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
  • Health Sciences › Medicine › Ophthalmology › Glaucoma and retinal disorders
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
Keywords
erythropoietin, retinal ganglion cells, axotomy, optic nerve transection, neuroprotection, ERK signaling, Akt signaling, caspase-3, Bcl-xL, STAT5, EPO receptor, transgenic mice, PD98059, wortmannin, optic neuropathy
MeSH terms
Animals, DNA-Binding Proteins, Enzyme Activation, Erythropoietin, Humans, Male, Mice, Transgenic, Milk Proteins, Nerve Degeneration, Optic Nerve, Protein-Tyrosine Kinases, Proto-Oncogene Proteins, Retina, Retinal Ganglion Cells, Signal Transduction, Trans-Activators, Protein Serine-Threonine Kinases, Receptors, Erythropoietin, Neuroprotective Agents, Proto-Oncogene Proteins c-bcl-2, Axotomy, Phosphatidylinositol 3-Kinases, Mitogen-Activated Protein Kinase 1, Caspases, JNK Mitogen-Activated Protein Kinases, Mitogen-Activated Protein Kinase 3, STAT5 Transcription Factor, bcl-X Protein, Proto-Oncogene Proteins c-akt, Mice, Caspase 3, Janus Kinase 2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Erythropoietin protects from axotomy-induced degeneration of retinal ganglion cells by activating ERK-1/-2. https://app.cochat.ai/papers/10.1096/fj.04-2493fje
The paper
Kilic, Ü., Kilic, E., Soliz, J., Bassetti, C. L., Gassmann, M., & Hermann, D. M. (2005). Erythropoietin protects from axotomy-induced degeneration of retinal ganglion cells by activating ERK-1/-2. The FASEB Journal. https://doi.org/10.1096/fj.04-2493fje

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.